ADVANCED HER2-NEGATIVE BREAST CANCER
Clinical trials for ADVANCED HER2-NEGATIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED HER2-NEGATIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for ADVANCED HER2-NEGATIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New oral paclitaxel combo shows promise for tough breast cancer
Disease control Not yet recruitingThis study tests an oral form of the chemotherapy drug paclitaxel, taken daily or several times a week, for adults with advanced HER2-negative breast cancer. The trial has two parts: first, finding the safest dose of the oral paclitaxel alone, and then testing it combined with th…
Matched conditions: ADVANCED HER2-NEGATIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated Jun 05, 2026 12:10 UTC
-
New real-world study tracks eribulin effectiveness in tough breast cancer cases
Knowledge-focused Not yet recruitingThis study observes 400 adults with advanced HER2-negative breast cancer who have already received antibody-drug conjugates. Researchers will track how long patients stay cancer-free or alive after starting eribulin-based therapy. The goal is to understand real-world treatment ou…
Matched conditions: ADVANCED HER2-NEGATIVE BREAST CANCER
Sponsor: Fudan University • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:53 UTC